Lv21
180 积分 2022-09-05 加入
Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: a systematic review and meta-analysis
2小时前
待确认
Epidemiological and clinical characteristics of hepatocellular carcinoma in Xiamen
19天前
已完结
Increasing functional cure rates after nucleo(s)tide analogue withdrawal: is peg-IFN the answer?
28天前
已完结
Machine learning models to further identify advantaged populations that can achieve functional cure of chronic hepatitis B virus infection after receiving Peg-IFN alpha treatment
28天前
已完结
Association of Vitamin D with Functional Cure in Chronic Hepatitis B: Insights from A Retrospective Cohort Study and An Intervention Study
1个月前
已完结
ALT to qHBsAg ratio predicts HBsAg seroclearance in HBeAg-negative hepatitis B patients with Peg-IFN-α-based therapy
1个月前
已完结
Does siRNA-based therapy require pegylated interferon-alfa-2a to cure HBV infection?
1个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
1个月前
已完结
PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial
1个月前
已完结
Finite nucleos(t)ide-analogue therapy for functional cure in HBeAg-negative chronic hepatitis B: recent development in the paradigm shift
2个月前
已完结
皖公网安备34019202002308
